摘要
近20年来随着血管内治疗的成熟与发展,支架植入术越来越多的应用于缺血性脑血管病的防治。而支架内再狭窄却限制了这一技术的广泛应用。大量的荟萃研究针对支架内再狭窄的危险因素、发病机制进行了探讨并达成了一些共识。公认的危险因素为糖尿病,公认的发病机制为血管内膜损伤。发现预测支架内再狭窄的因素对支架内再狭窄的预防及治疗有着重要作用。
With the maturity and development of endovascular techniques in recent 20 years, stent implantation is more and more used in the prevention and treatment of ischemic cerebrovascular disease. In-stent restenosis has limited the wide application of this technology. A large number of studies on the risk factors and pathogenesis of in-stent restenosis have been discussed and some consensus has been reached. Recognized risk factors is diabetes and the pathogenesis is vascular intimal injury. It was found that the factors prediction of in-stent restenosis play an important role in the prevention and treatment of restenosis.
出处
《中华临床医师杂志（电子版）》
CAS
2017年第1期87-90,共4页
Chinese Journal of Clinicians(Electronic Edition)
基金
山西省科技局课题(2015140)
